Ming Yan is a Senior Principal Scientist at Novartis Precision Medicine, bringing over nine years of expertise in Clinical Trial Assay (CTA) and Companion Diagnostics (CDx) development. They have led significant contributions to drug submissions and approvals in both the U.S. and Japan, and possess extensive experience with next-generation sequencing technologies. Having previously worked as a Principal Scientist and Tech Lead, Ming has demonstrated strong leadership through mentoring junior associates and fostering partnerships for CDx development. Ming holds postdoctoral training in Microbiology and Vaccine Development from Harvard Medical School and continues their studies at Nanjing University and the Chinese Academy of Science.
This person is not in the org chart
This person is not in any teams
This person is not in any offices